Nolato: Nolato’s Best Year Yet

Regulatory News:

In today’s year-end report, Nolato (STO:NOLAB) is reporting a 17 per cent increase in sales to 4,522 MSEK (3,874) for the financial year 2013. Operating profit (EBITA) rose by as much as 41 per cent to 427 MSEK (303) and earnings per share rose to 11.94 SEK (7.68). Cash flow after investments was strong and totalled 362 MSEK (317), excluding acquisitions and disposals. The Board proposes a dividend of 8.00 SEK (6.00), of which 4.00 SEK (2.50) constitutes an extra dividend as a result of the group’s strong financial position.

"In recent years we have focused on creating a balanced group structure with three business areas, which we have achieved along with continuous enhancement of our profitability. Amongst other things, this strategic direction has led to a series of successful acquisitions at Nolato Medical, which is currently responsible for around 30 per cent of group turnover,” said Nolato’s President and CEO Hans Porat.

Nolato’s business model is based on close, long-term and innovative collaboration that creates added value both for customers and shareholders. The work has made the 2013 financial year the best to date in Nolato’s history, with sales of just over 4,5 billion SEK and an operating margin (EBITA) of 9.4 per cent.

"A good level of profitability has been, and remains, our highest priority, which means we are constantly seeking to implement improvements in the areas of efficiency and productivity. In addition, we have dedicated considerable resources to developing skills in the group in respect of project management and technical development, including learning from each other, so that we are the natural choice for our customers both now and in the future,” said Nolato’s President and CEO Hans Porat.

At the turn of the year, the equity/assets ratio stood at 52 per cent (44) and net financial assets at 122 MSEK (–113).

"Thanks to our strong cashflow in recent years, and notwithstanding the acquisitions we have made, our financial position is very good and we are therefore in a position to finance new acquisitions while maintaining the ability to pay dividends,” said Nolato’s President and CEO Hans Porat.

The Annual General Meeting will be held in Grevie, Sweden on 28 April at 4 pm. The Board proposes a dividend of 8.00 SEK (6.00) of which 4.00 (2.50) constitutes an extra dividend as a result of the group’s strong financial position.

Nolato is a high-tech developer and manufacturer of polymer products for leading customers in medical technology, telecommunications, hygiene, automotive and other selected industrial sectors. Its B shares are listed on the NASDAQ OMX Stockholm, where Nolato is a Mid Cap company in the Industrials sector.

The information is such which Nolato AB is obliged to disclose under the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. This information was made public on 4 February 2014 at 2.30 pm.

www.nolato.com

This information was brought to you by Cision http://news.cision.com